Funding news
Immunocan logo

Immunocan Raises $37.

Recently funded · $37.0M Series aTechnology, Information and MediaUSView source

Get the full Immunocan company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Immunocan, the Shanghai-based biotechnology firm dedicated to building innovative antibody drug discovery platforms, has secured $37.0M in Series A funding. The company, founded in 2020, leverages proprietary gene editing technology to develop animal platforms capable of generating human and alpaca antibodies.

This specialized approach aims to empower global antibody drug R&D, offering versatile tools for a range of discovery scenarios. The capital infusion marks a significant step for Immunocan as it continues its work.

From the source

Refery · Jun 3, 2026

From Bangalore to Beijing to Sydney: $1B raised across 27 APAC startups last week 👇 ▪ MEGA DEALS 🛵 Rapido | Bike taxi & ride-hailing in India | $490M Growth | Accel, Nexus, Swiggy 🚗 Semidrive 芯驰科技 | Smart driving chips for ADAS | $100M Series C | Matrix Partners China, CATL 🧬 PepLib | Peptide drug discovery | $44M Series C | Gaorong, CDH 💉 Starna Therapeutics | RNA-core drug delivery | $40M Series B | Hillhouse, Lilly Asia ▪ SERIES A & B 🧪 Degron Therapeutics | Targeted protein degradation drugs | $40M Series A 🩸 Immunocan | Fully human antibodies for tumors | $37M Series A 💄 Konvy | Beauty e-commerce in Thailand | $22M Series B 🧫 SPARK Biopharma, Inc.

| Image-based drug screening | $21M Series A 🏗️ Xpanner | AI & robotics for construction | $18M Series B 🛰️ Arkeus | AI sensing for autonomous defense | $17.9M Series A 🚙 movus technologies | Car rental in Indonesia | $16.4M Series B 💊 YIRUI Pharmaceutical Technology | Drugs for chronic skin diseases | $14.7M Series A ⚙️ HrdWyr | AI chips & edge computing | $13M Series A 🥫 WINGREENS WORLD | I

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Layup Parts logo

Layup Parts

United States

$42.0M
2
Board logo

Board

United States

$20.0M
3
Alitheon logo

Alitheon

United States

$8.0M
4
Tavo Biotherapeutics logo

Tavo Biotherapeutics

$17.0M
5
Adaptive Innovations Corp logo

Adaptive Innovations Corp

United States

$50.0M